
Kronox Lab Sciences Q2 Results FY27 Preview: Results Date, Preview and Expectations for Investors
Kronox Lab Sciences CMP Rs 174.49, market cap Rs 647 crore. Q1 FY27 (Jun 2026) revenue was Rs 28.39 crore with Rs 7.30 crore net profit.
Updated: 18 Sept 2026 • 12:09 pm
Posted by:

Track the latest Kronox Lab Sciences Ltd. share price on Univest. This is a point investors are watching closely around Kronox Lab Sciences Q2 results. This is a point investors are watching closely around Kronox Lab Sciences Q2 results.
Investors tracking the Kronox Lab Sciences Q2 results are already watching for the exact announcement date, even though the specialty chemicals maker has not yet made any formal disclosure. This Kronox Lab Sciences Q2 results preview walks through what the historical data suggests, the recent quarterly trend, and the metrics worth watching, without inventing any numbers that the company itself has not reported. It remains a relevant data point for Kronox Lab Sciences Q2 results watchers. It remains a relevant data point for Kronox Lab Sciences Q2 results watchers.
Open a free demat account with Univest
Kronox Lab Sciences Q2 Results Date: When Will It Be Announced?
The exact Kronox Lab Sciences Q2 results date for the September 2026 quarter has not been officially announced yet. Based on the company's historical results calendar pattern, Q2 FY27 results are typically expected to be released in the second half of October or early November 2026. Investors searching for the Kronox Lab Sciences q2 results date should keep an eye on the exchange filings on the NSE and BSE as the quarter draws to a close, since the board meeting intimation is usually issued about a week before the actual announcement. Analysts tracking Kronox Lab Sciences Q2 results will note this trend. Analysts tracking Kronox Lab Sciences Q2 results will note this trend.
Until an official Kronox Lab Sciences q2 results date is confirmed, any specific date mentioned elsewhere should be treated as an estimate rather than a confirmed schedule. This detail is part of the broader Kronox Lab Sciences Q2 results discussion this quarter. This detail is part of the broader Kronox Lab Sciences Q2 results discussion this quarter.
Kronox Lab Sciences Q2 Results Expectations: What Metrics Matter
Also read – Gabriel India Q2 Results FY27 Preview
Rather than predicting specific revenue or profit figures, this Kronox Lab Sciences q2 results expectations section focuses on the trends investors should track. The company has posted operating margins consistently in the 31 to 36 percent band over the last five quarters, and whether that band holds or expands will be a key data point for Q2 FY27. It is one more data point relevant to Kronox Lab Sciences Q2 results.
Investors building q2 results expectations for Kronox Lab Sciences will likely watch whether revenue growth continues the sequential rise seen through FY26, whether the operating profit margin (OPM) stays close to the Q2 FY26 base of 33.88 percent, and whether net profit tracks the top line proportionally. These are trend based expectations, not numeric forecasts, since the company has not issued any guidance for the quarter. This adds useful context to Kronox Lab Sciences Q2 results for investors.
Start investing today with a free Univest demat account
Kronox Lab Sciences Q1 FY27 (June 2026 Quarter) Performance
In the June 2026 quarter (Q1 FY27), Kronox Lab Sciences reported revenue of Rs 28.39 crore, operating profit of Rs 8.99 crore, an operating profit margin of 31.67 percent, and a net profit of Rs 7.30 crore. This was the highest quarterly revenue in the trailing five quarter window, even though the operating margin moderated slightly from the 36.43 percent seen in the preceding March 2026 quarter. Market watchers following Kronox Lab Sciences Q2 results will keep this in view.
The Q1 FY27 print gives investors a fresh sequential base heading into the Q2 FY27 results season, and the coming quarter's numbers will be read against both this June 2026 print and the year ago September 2025 quarter. This remains relevant background for Kronox Lab Sciences Q2 results.
Kronox Lab Sciences Q2 FY26 (September 2025 Quarter): The YoY Base
The September 2025 quarter, which forms the base for the upcoming year on year comparison, saw Kronox Lab Sciences post revenue of Rs 25.53 crore, operating profit of Rs 8.65 crore, an operating profit margin of 33.88 percent, and a net profit of Rs 6.68 crore. This was actually the strongest margin quarter in the entire five quarter data set available. It is worth noting in the context of Kronox Lab Sciences Q2 results.
Since Q2 FY26 carried the highest operating profit margin of the period, Q2 FY27 will need a meaningfully higher revenue base for net profit to grow at a similar pace year on year, unless margins expand further from current levels. This is part of the broader picture around Kronox Lab Sciences Q2 results.
Recent Quarterly Trend: Jun25 to Jun26
Looking at the full run from June 2025 to June 2026 gives a clearer picture of the underlying trend than any single quarter. Revenue moved from Rs 24.29 crore in Jun25 to Rs 25.53 crore in Sep25, Rs 25.27 crore in Dec25, Rs 26.13 crore in Mar26, and Rs 28.39 crore in Jun26. That is a steady, if gradual, uptrend over the year. Investors tracking Kronox Lab Sciences Q2 results may find this useful context.
Operating profit margin, however, has moved in more of a range, from 32.81 percent in Jun25 down to 31.78 percent in Dec25, up to a high of 36.43 percent in Mar26, and back to 31.67 percent in Jun26. Net profit has broadly tracked this margin swing, rising from Rs 6.28 crore to Rs 8.00 crore in Mar26 before easing to Rs 7.30 crore in Jun26. There were no exceptional items flagged across any of these quarters, according to available screener data, so this pattern reflects core operating performance. This adds to the overall picture for Kronox Lab Sciences Q2 results.
Also read – Gala Precision Engineering Q2 Results FY27 Preview
Key Factors to Watch This Quarter
A few factors are worth watching as the Kronox Lab Sciences q2 results FY27 approach. First, whether the open offer context involving Indo Borax and Zenrock, which has been a corporate action talking point, has any bearing on business operations or is purely a shareholding related event. Second, whether the operating margin can hold above the 31 to 32 percent floor seen in the weaker quarters of the trailing year. Third, whether the revenue uptrend visible since Dec25 continues into the September 2026 quarter.
Investors will also want to watch working capital trends and any commentary on capacity utilisation, since the specialty chemicals segment tends to be sensitive to both raw material costs and export demand cycles.
Open your free demat account on Univest now
Kronox Lab Sciences Valuation Snapshot
At the current market price of Rs 174.49, Kronox Lab Sciences trades at a price to earnings (PE) ratio of 22.63 times and a price to book (PB) ratio of 5.57 times, against a book value of Rs 31.30 per share. The stock's trailing EPS stands at Rs 7.71, and return on equity (ROE) is a healthy 26.8 percent, with a low debt to equity (D/E) ratio of just 0.02, indicating the company carries almost no debt on its books.
The stock offers a modest dividend yield of 0.29 percent. On the 52 week range, Kronox Lab Sciences has traded between a low of Rs 96.00 and a high of Rs 223.42, and the current price sits above both the 50 day moving average of Rs 155.70 and the 200 day moving average of Rs 148.08. The relative strength index (RSI) reading of 44.75 suggests the stock is currently in a neutral zone, neither overbought nor oversold. Market capitalisation stands at approximately Rs 647 crore.
What to Watch in Q2 FY27
Heading into the q2 results 2026 season, the key data points to track when Kronox Lab Sciences eventually announces its results will be the revenue growth rate versus both the immediate previous quarter and the September 2025 base, the operating profit margin trajectory, and any management commentary on demand from key end markets. This kind of q2 results preview is meant to frame the right questions rather than predict the answers.
Conclusion
This Kronox Lab Sciences q2 results preview has laid out the historical trend, the year ago base quarter, and the valuation context without forecasting any specific revenue or profit number for Q2 FY27. Investors should wait for the company's official announcement and read the actual results alongside the trends discussed here, rather than treating any estimate as confirmed. As always, this is informational content and not a recommendation of any kind.
Disclaimer: This article is for informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any security. Univest Comtrade Private Limited (SEBI Research Analyst Registration No. INH000013776) does not guarantee the accuracy, completeness, or timeliness of the information provided. Investors should conduct their own research or consult a qualified financial advisor before making any investment decisions. Investments in securities are subject to market risks; please read all related documents carefully before investing.
When will Kronox Lab Sciences announce its Q2 FY27 results?
Ans. The exact Kronox Lab Sciences q2 results date has not been officially announced yet. Based on the company's historical results calendar pattern, the announcement is typically expected in the second half of October or early November 2026.
What was Kronox Lab Sciences revenue in Q1 FY27?
Ans. In the June 2026 quarter, Kronox Lab Sciences reported revenue of Rs 28.39 crore with an operating profit margin of 31.67 percent and net profit of Rs 7.30 crore.
How did Kronox Lab Sciences perform in the Q2 FY26 base quarter?
Ans. In the September 2025 quarter, which is the base for the year on year comparison, Kronox Lab Sciences posted revenue of Rs 25.53 crore, an operating profit margin of 33.88 percent, and net profit of Rs 6.68 crore.
What is the current valuation of Kronox Lab Sciences shares?
Ans. Kronox Lab Sciences trades at a PE ratio of 22.63 times and a PB ratio of 5.57 times as of the current market price of Rs 174.49, with a return on equity of 26.8 percent and negligible debt on its books.
Recent Articles

Marico Q2 Results FY27: Date, Expectations and Preview
18 September 2026

Marathon Nextgen Realty Q2 Results FY27: Date, Expectations and Preview
18 September 2026

Maral Overseas Q2 Results FY27: Date, Expectations and Preview
18 September 2026

Manomay Tex India Q2 Results FY27: Date, Expectations and Preview
18 September 2026
Note: This blog is for information purpose only. Investments and trading are subject to market risks, read all scheme related documents carefully.
Reviews
Recent Posts
Marico Q2 Results FY27: Date, Expectations and Preview
Marathon Nextgen Realty Q2 Results FY27: Date, Expectations and Preview
Maral Overseas Q2 Results FY27: Date, Expectations and Preview
Manomay Tex India Q2 Results FY27: Date, Expectations and Preview
Keystone Realtors Q2 Results FY27: Date, Expectations and Preview
Popular this week
Kwality Wall's Q2 Results FY27: Date, Expectations and Preview

Uniresearch Global Pvt Ltd
Research Analyst
SEBI Registration Number — INH000013776
Uniresearch is a subsidiary of Univest Communication Technologies Private Limited
Company Address: Registered Address: Ground Floor, Unitech Commercial Tower 2, Block B, Greenwood City, Unit 1-3, Sector 45, Gurugram, Haryana 122003
Write to us : support@univest.in, compliance@univest.in
Verify on SEBI registry →RESEARCH ANALYST
Get SEBI Registered
advice on the stocks
trending today.
Get 3 FREE Trade Ideas
for Startups Accelerator 2024
Trusted by 1Cr Indians
Awarded No.1 by Economic Times





